IQVIA, a provider of clinical research services and healthcare intelligence, has unveiled a new set of AI agents at NVIDIA GTC Paris. Developed in collaboration with NVIDIA, these custom-built agents are designed to enhance workflows and speed up insights across the life sciences sector. Built using NVIDIA technologies such as NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails, the AI agents can support use cases including clinical data review, literature analysis, market assessment, and healthcare professional engagement. “This is a pivotal opportunity to deliver the precise, efficient workflows and insights required by the modern life sciences industry,” said Bhavik Patel, President of IQVIA Commercial Solutions.
IQVIA’s AI agents draw on Healthcare-grade AI and vast healthcare-specific data to help clients conduct research and clinical trials more effectively. Kimberly Powell, Vice President of Healthcare at NVIDIA, stated, “Working with industry leaders like IQVIA, we can build domain-specific agents that can demonstrate efficiency and precision.” The collaboration between the two companies, announced earlier this year, aims to bring advanced AI capabilities to the entire asset lifecycle in life sciences.